Thursday, October 12, 2017 5:46:36 AM
BEARS called out:
https://www.sec.gov/Archives/edgar/data/1269026/000149315217011512/form8k.htm
Proposal # 1:
(For) 18,211,006 + (Against) 6,343,473 + (Abstain) 168, 131 = 24,722,610 shares voted
Proposal # 2:
(For) 18,552,800 + (Against) 5,927,971 + (Abstain) 241,840 = 24,722,611 shares voted
So:
OS = 36,200,000 shares – 24,722,610 shares = 11,477,390 shares DIDN’T VOTE
Compares to the PR on September 07, 2017:
“Over 13 million shares -- representing nearly 36% of the outstanding common stock -- remained unvoted as of the time of today's meeting.”
http://investors.amedica.com/press-releases/detail/103/amedica-announces-adjournment-of-special-meeting-of"
In 35 calendar days, roughly 1.5Mils extra shares voted.
The voting ended as soon as they hit 50.31%:
18,211,006 / 36,200,000 = .503066
====================================================
Last deadline to be over $1 bid price was August 14th, 2017. If they really wanted to fix the $1 bid price issue, they would have voted back in early July 2017 & would have effectuated the R/S in late July 2017.
As I have mentioned a few times back, the R/S voting only serves 3 purposes:
#1 – Buy time to wrap up thing up like M&A (see 2 examples below)
#2 – to adjust the OS for Change of Control to match the executive incentive plan (10%)
#3 – share exchange w/ the suitor on M&A
Now R/S is already approved - ready to rock & roll! There is NO reason that Nasdaq will reject their plans, hence will grant AMDA extra time (around 4 months).
============ AMDA current situation to stay listed =================
1*Received Delisting Letter (used up all extensions) = 08.22.2017
2*Notify Investors Regarding Delisting Letter = 08.25.2017
3*Request Oral Hearing = Receiving Delisting Letter + 7 days= 08.29.2017
4*Hearing Date = Request Oral Hearing + 45 days = 10.12.2017
5*Hearing Result From Nasdaq = Hearing Date + 14 days = 10.26.2017
6*Notify Investors Regarding Hearing Result = 10.27.2017
7*Granted Until (Bid price issue) = 02.17.2018
*** RECEIVED Delisting Letter until new Deadline (180 days) ***
========== EXAMPLE 1 ======================
http://investors.vcel.com/releasedetail.cfm?releaseid=429181
http://investors.vcel.com/secfiling.cfm?filingID=950123-09-69583&CIK=887359
Received Delisting Letter (Exhausted all allow extensions) = 10.02.2009
Notify Investors Regarding Delisting Letter = 10.07.2009
Request Oral Hearing = Receiving Delisting Letter + 7 days = 10.09.2009
Hearing Date = Request Oral Hearing + 45 days = 11.24.2009
Hearing Result From Nasdaq = Hearing Date + 14 days = 12.08.2009
Notify Investors Regarding Hearing Result = 12.09.2009
Granted Until = 03.31.2010
*** RECEIVED Delisting Letter until new deadline = 180 days ***
======= EXAMPLE 2 =========================
http://ir.cytori.com/investor-relations/news/news-details/2015/Cytori-to-Address-Nasdaq-Listing-via-Nasdaq-Hearing-Panel/default.aspx
https://www.sec.gov/Archives/edgar/data/1095981/000109598116000042/form8k.htm
“As Cytori reported on December 7, 2015, it received a determination letter from the Nasdaq staff stating that it has yet to regain compliance with the minimum bid price requirement fo”
“The hearing will occur on January 21, 2016 at Nasdaq’s Washington, D.C. offices. “
“n or before May 31, 2016, and its continued compliance with all other applicable rules for continued listing on The NASDAQ Capital Market.”
They received letter on the December 3rd, 2015 + 180 days = May 31st, 2016"
http://ir.cytori.com/investor-relations/news/news-details/2015/Cytori-to-Address-Nasdaq-Listing-via-Nasdaq-Hearing-Panel/default.aspx
============== EXAMPLE 3 ====================
Nasdaq even grants extra time while the M&A deal is being close:
http://www.marketwired.com/press-release/poniard-pharmaceuticals-receives-favorable-nasdaq-decision-continued-listing-company-nasdaq-pard-1557317.htm
*** ONLY if there is no more time for any extra extension to stay listed, but we got plenty of time ***
=============================================
BEARS are/were spinning (grasping more likely):
#1 OTC = Delisting = If R/S voting would not get approved <<< NO MORE (R/S approved!)
#2 Effectuate R/S right away = If R/S voting get approved <<< NOT GONNA HAPPEN = 3 above examples
#3 Wow Dilution coming <<< NO UPDATED Quarter Results Yet & 10-K said “NO S-3”
Any of these ever happened, that would be a dream come true for the BEARS, right?
But…..Why the BEARS keep on covering their short positions if they believe these above 3 events will happen soon!!!??? GRASPING!
http://www.nasdaq.com/symbol/amda/short-interest
THEY ARE COVERING! BEARS are so cute! ILLOGICAL!
Is it because #4 = M&A in the work & news is around the corner?
Tons of info from last sticky post & links back to Boston’s DDs as well:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134940310
M&A evidences are stacked up as high as Mt. Everest! Wink as the BEARS!
===============================================
Let do some calculations on the Incentive Plans in case of Change of Control:
“in light of our compensation strategy and objectives. Accordingly, the Board is proposing to increase the number of shares available under the 2012 Plan by 800,000 shares, from 342,425 to 1,142,425, increasing the percentage ratio of the amount of shares available under the Plan to 10.0% of outstanding shares as of March 28, 2016.”
https://www.sec.gov/Archives/edgar/data/1269026/000149315216008810/def14a.htm
(Page 16)
Method #1:
Roughly about 55 mils shares (fully diluted)
10% = 5.5 mils shares, so they have to ask for approval of (5.5 mils – 1,142,425 shares) = around 4.4 mils shares (this method sounds aggressive!)…but they already asked once on last year proxy! Why do double work & vote again? Double vote?
Or
Method #2:
5:1 R/S = 55mils /5 Mils = 11mils shares OS X 10% = 1.1 Mils almost equates to (1,142,425)!!! You see how magical the R/S works? (I believe this method sounds better.) & R/S voting is already approved – ready to rock & roll! This also explains why they were SO RUSH to set up a voting for R/S – wink at the BEARS again, right? Hence, the covering! The BEARS know about this that was why they kept told the BULLS to vote no!
& of course:
Shares swapping with Zimmer purpose (I doubt Zimmer will pay cash for the deal = Tax advantage & other reasons):
If R/S ever be used to coordinate with share swapping in conjunction with swap ratio, it will only effect under 2 situations & it will be spelled out CLEARLY ON THE M&A NEWS:
PRIOR TO THE MERGER …
OR
PRIOR TO THE CLOSING OF THE MERGER…
You can find examples of the news announcements from my previous posts:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133775048
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133838866
===========================================
Long & Strong until M&A news!!!
Long should hold tight!
Don’t let the BEARS take your shares & cover!
I will post some more info later.
Recent SINT News
- SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT • GlobeNewswire Inc. • 04/29/2024 01:14:20 PM
- SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock • GlobeNewswire Inc. • 04/03/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/29/2024 08:00:00 PM
- SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock • GlobeNewswire Inc. • 03/25/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET • GlobeNewswire Inc. • 02/21/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 02:00:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:12:54 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/07/2024 09:42:32 PM
- SINTX Technologies Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 02/02/2024 07:33:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 11:30:20 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/01/2024 10:14:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:22 AM
- SINTX Technologies Announces Pricing of $4.0 Million Public Offering • GlobeNewswire Inc. • 01/31/2024 02:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 11:05:14 AM
- SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY • GlobeNewswire Inc. • 01/30/2024 09:01:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:05:13 PM
- SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE • GlobeNewswire Inc. • 01/23/2024 02:00:00 PM
- SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:10:37 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/28/2023 09:44:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 03:10:10 PM
- SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS • GlobeNewswire Inc. • 11/07/2023 02:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM